What is 20/20 Biolabs, Inc. Common Stock's Market Cap?

20/20 Biolabs, Inc. Common Stock's Market Cap is $7.4M, based on as-reported figures from SEC (XBRL) filings.

What is 20/20 Biolabs, Inc. Common Stock's Enterprise Value?

20/20 Biolabs, Inc. Common Stock's Enterprise Value is $3.2M, based on as-reported figures from SEC (XBRL) filings.

What is 20/20 Biolabs, Inc. Common Stock's Price / Sales?

20/20 Biolabs, Inc. Common Stock's Price / Sales is 4.0×, based on as-reported figures from SEC (XBRL) filings.

What is 20/20 Biolabs, Inc. Common Stock's EV / Revenue?

20/20 Biolabs, Inc. Common Stock's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.

What is 20/20 Biolabs, Inc. Common Stock's EV / EBITDA?

20/20 Biolabs, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is 20/20 Biolabs, Inc. Common Stock's Revenue (TTM)?

20/20 Biolabs, Inc. Common Stock's Revenue (TTM) is $1.8M, based on as-reported figures from SEC (XBRL) filings.

What is 20/20 Biolabs, Inc. Common Stock's Net Income (TTM)?

20/20 Biolabs, Inc. Common Stock's Net Income (TTM) is -$5.1M, based on as-reported figures from SEC (XBRL) filings.

What is 20/20 Biolabs, Inc. Common Stock's EBITDA?

20/20 Biolabs, Inc. Common Stock's EBITDA is -$3.9M, based on as-reported figures from SEC (XBRL) filings.

What is 20/20 Biolabs, Inc. Common Stock's Diluted EPS (TTM)?

20/20 Biolabs, Inc. Common Stock's Diluted EPS (TTM) is -0.40, based on as-reported figures from SEC (XBRL) filings.

What is 20/20 Biolabs, Inc. Common Stock's EBITDA Margin?

20/20 Biolabs, Inc. Common Stock's EBITDA Margin is -213.8%, based on as-reported figures from SEC (XBRL) filings.

20/20 Biolabs, Inc. Common Stock (AIDX) Financial Statements

20/20 Biolabs, Inc. Common Stock

SIC 8734 · SERVICES-TESTING LABORATORIES

FIGI BBG01ZZ5RTV4

XNAS · usd

0.58▼ 0.01 (-2.30%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close0.59

Day's Range0.57 – 0.60

52-Week Range0.40 – 50.00

Volume18.2K

Avg Volume94.3K

Share Statistics

Shares Outstanding

Employees14

ExchangeXNAS

Listed2026-02-19

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about 20/20 Biolabs, Inc. Common Stock (AIDX)

What is 20/20 Biolabs, Inc. Common Stock's Market Cap?: 20/20 Biolabs, Inc. Common Stock's Market Cap is $7.4M, based on as-reported figures from SEC (XBRL) filings.
What is 20/20 Biolabs, Inc. Common Stock's Enterprise Value?: 20/20 Biolabs, Inc. Common Stock's Enterprise Value is $3.2M, based on as-reported figures from SEC (XBRL) filings.
What is 20/20 Biolabs, Inc. Common Stock's Price / Sales?: 20/20 Biolabs, Inc. Common Stock's Price / Sales is 4.0×, based on as-reported figures from SEC (XBRL) filings.
What is 20/20 Biolabs, Inc. Common Stock's EV / Revenue?: 20/20 Biolabs, Inc. Common Stock's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is 20/20 Biolabs, Inc. Common Stock's EV / EBITDA?: 20/20 Biolabs, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is 20/20 Biolabs, Inc. Common Stock's Revenue (TTM)?: 20/20 Biolabs, Inc. Common Stock's Revenue (TTM) is $1.8M, based on as-reported figures from SEC (XBRL) filings.
What is 20/20 Biolabs, Inc. Common Stock's Net Income (TTM)?: 20/20 Biolabs, Inc. Common Stock's Net Income (TTM) is -$5.1M, based on as-reported figures from SEC (XBRL) filings.
What is 20/20 Biolabs, Inc. Common Stock's EBITDA?: 20/20 Biolabs, Inc. Common Stock's EBITDA is -$3.9M, based on as-reported figures from SEC (XBRL) filings.
What is 20/20 Biolabs, Inc. Common Stock's Diluted EPS (TTM)?: 20/20 Biolabs, Inc. Common Stock's Diluted EPS (TTM) is -0.40, based on as-reported figures from SEC (XBRL) filings.
What is 20/20 Biolabs, Inc. Common Stock's EBITDA Margin?: 20/20 Biolabs, Inc. Common Stock's EBITDA Margin is -213.8%, based on as-reported figures from SEC (XBRL) filings.